Paper Review Records
All Paper Review Records
10 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
16
days
Peptide-based pan-CoV fusion inhibitors maintain high potency against SARS-CoV-2 Omicron variant
Authors
Shuai Xia; Jasper Fuk-Woo Chan; Lijue Wang; Fanke Jiao; Kenn Ka-Heng Chik; Hin Chu; Qiaoshuai Lan; Wei Xu; Qian Wang; Chao Wang; Kwok-Yung Yuen; Lu Lu; Shibo JiangShow moreShow less
Affiliations
1. Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences, Shanghai Frontiers Science Center of Pathogenic Microbes and Infection, Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai, China; 2. State Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, China; 3. Department of Clinical Microbiology and Infection Control, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China; 4. Centre for Virology, Vaccinology and Therapeutics, Hong Kong Science and Technology Park, Hong Kong, China; 5. State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing, ChinaShow moreShow less
96
days
Heterogeneity in endothelial cells and widespread venous arterialization during early vascular development in mammals
Authors
Siyuan Hou; Zongcheng Li; Ji Dong; Yun Gao; Zhilin Chang; Xiaochen Ding; Shuaili Li; Yunqiao Li; Yang Zeng; Qian Xin; Baihan Wang; Yanli Ni; Xiaowei Ning; Yuqiong Hu; Xiaoying Fan; Yu Hou; Xianlong Li; Lu Wen; Bin Zhou; Bing Liu; Fuchou Tang; Yu LanShow moreShow less
Affiliations
1. Key Laboratory for Regenerative Medicine of Ministry of Education, Institute of Hematology, School of Medicine, Jinan University, Guangzhou, China; 2. State Key Laboratory of Experimental Hematology, Haihe Laboratory of Cell Ecosystem, Institute of Hematology, Fifth Medical Center of Chinese PLA General Hospital, Beijing, China; 3. Integrated Chinese and Western Medicine Postdoctoral Research Station, Jinan University, Guangzhou, China; 4. Beijing Advanced Innovation Center for Genomics and Biomedical Pioneering Innovation Center, School of Life Sciences, Peking University, Beijing, China; 5. State Key Laboratory of Proteomics, Academy of Military Medical Sciences, Academy of Military Sciences, Beijing, China; 6. Ministry of Education Key Laboratory of Cell Proliferation and Differentiation, Beijing, China; 7. The State Key Laboratory of Cell Biology, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, China; 8. Peking-Tsinghua Center for Life Sciences, Peking University, Beijing, ChinaShow moreShow less
8
days
Reduced interferon antagonism but similar drug sensitivity in Omicron variant compared to Delta variant of SARS-CoV-2 isolates
Authors
Denisa Bojkova; Marek Widera; Sandra Ciesek; Mark N. Wass; Martin Michaelis; Jindrich CinatlShow moreShow less
Affiliations
1. Institute for Medical Virology, University Hospital, Goethe University, Frankfurt am Main, Germany; 2. German Center for Infection Research, DZIF, External Partner Site Frankfurt am Main, Frankfurt am Main, Germany; 3. Fraunhofer Institute for Molecular Biology and Applied Ecology (IME), Branch Translational Medicine und Pharmacology, Frankfurt am Main, Germany; 4. School of Biosciences, University of Kent, Canterbury, UK; 5. Dr. Petra Joh-Forschungshaus, Frankfurt am Main, GermanyShow moreShow less
5
days
SARS-CoV-2 Omicron variant is highly sensitive to molnupiravir, nirmatrelvir, and the combination
Authors
Pengfei Li; Yining Wang; Marla Lavrijsen; Mart M. Lamers; Annemarie C. de Vries; Robbert J. Rottier; Marco J. Bruno; Maikel P. Peppelenbosch; Bart L. Haagmans; Qiuwei PanShow moreShow less
Affiliations
1. Department of Gastroenterology and Hepatology, Erasmus MC-University Medical Center, Rotterdam, the Netherlands; 2. Viroscience Department, Erasmus MC-University Medical Center, Rotterdam, the Netherlands; 3. Department of Pediatric Surgery, Erasmus MC-Sophia Children’s Hospital, Rotterdam, the Netherlands; 4. Department of Cell Biology, Erasmus MC-University Medical Center, Rotterdam, the NetherlandsShow moreShow less
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review62 days
Median65 days